Khabre branded placeholder image

science

CRISPRi Screen Maps Drug-Target Synergies in Tuberculosis Bacteria

A bioRxiv preprint reports a pooled CRISPRi screen that measured 1,326 pairwise genetic interactions among 51 Mycobacterium tuberculosis drug-target genes. Follow-up experiments found drug synergies involving ATP synthase targets and reported that inhibiting Pks13 potentiated antitubercular agents.

Khabre branded placeholder image

science

Researchers build TriComm, a continuous-culture model of plasmid resistance

A bioRxiv preprint describes TriComm, a three-strain microbial community maintained in continuous culture to study plasmid-mediated antimicrobial resistance. The authors report that resistance plasmids protected the community from collapse under antimicrobial treatment, with protection depending on plasmid transfer.

Khabre branded placeholder image

science

Screen links ibuprofen to ciprofloxacin tolerance in C. jejuni

A bioRxiv preprint reports that ibuprofen increased ciprofloxacin tolerance in Campylobacter jejuni in a screen of 2,415 small molecules. The same study identified human-targeted drugs that inhibited the bacterium while sparing commensal microbes.

Khabre branded placeholder image

science

TB preprint identifies Pks12’s role in cell-surface lipids

A bioRxiv preprint reports that the Pks12 enzyme helps generate a lipid that shapes the surface and arabinoglycan architecture of Mycobacterium tuberculosis. The researchers combined analysis of more than 50,000 bacterial isolates with validation in zebrafish and mouse models.

Khabre branded placeholder image

science

MERS-CoV Spike Mutations Resist Soluble DPP4 in Cell Experiments

A bioRxiv preprint reports that MERS-CoV spike substitutions L507I and L507H reduced binding to soluble DPP4 while preserving entry into cells with high DPP4 levels. Polymorphisms at the same site found in patient virus sequences showed stronger resistance in the study’s VSV-based cell system.

Khabre branded placeholder image

science

DNA repeat changes can alter drug susceptibility in Mycobacterium tuberculosis

A bioRxiv preprint reports that insertions and deletions in several classes of repeated DNA sequences can change antibiotic susceptibility in Mycobacterium tuberculosis. Laboratory reconstruction identified a ppe53 repeat deletion that produced intermediate resistance to isoniazid, rifampicin and streptomycin.

Khabre branded placeholder image

science

Genome-wide screens map E. coli genes used by RNA and DNA phages

A bioRxiv preprint maps bacterial host factors involved in infection by single-stranded RNA and DNA bacteriophages. The study identifies conserved requirements for F-pilus-dependent infection and links an E. coli capsule architecture to selective phage access.